Skip to content

Observation of the effectiveness and dominant dose of Remimazolam Besylate in inducing tracheal intubation

Observation of the effectiveness and dominant dose of Remimazolam Besylate in inducing tracheal intubation

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400093402
Enrollment
Unknown
Registered
2024-12-04
Start date
2024-12-15
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory failure

Interventions

P0 (Propofol 2mg/kg dose group):Propofol 2mg/kg induces sedation with tracheal intubation
R1 (Rimazolen benzenesulfonate 0.2mg/kg dose group):Induction of sedative tracheal intubation with 0.2 mg/kg Remimazolam besylate
R2 (Rimazolen benzenesulfonate 0.3mg/kg dose group):Induction of sedative tracheal intubation with 0.3 mg/kg Remimazolam besylate
R3 (Rimazolen benzenesulfonate 0.4mg/kg dose group):Induction of sedative tracheal intubation with 0.4 mg/kg Remimazolam besylate

Sponsors

The first affiliated hostipal of nanchang university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Age range from 18 to 80 years old, gender not limited; 2.BMI 18~ 30 kg /m^2; 3.The emergency department requires endotracheal intubation and sedation treatment; 4.Obtain informed consent from patients or their families.

Exclusion criteria

Exclusion criteria: 1. Those who are known or suspected to be allergic or contraindicated to various components of the experimental drugs involved in the research; 2.Individuals with a known history of severe mental illness; 3.Patients whose blood pressure cannot be maintained to systolic blood pressure >= 90mmHg and MAP >= 65mmHg before intubation induction; 4. Coma patients; 5. Patients with myasthenia gravis; 6. Pregnant and lactating women; 7. Individuals who have experienced tracheotomy, difficult intubation, or airway stenosis; 8.Alcoholism or long-term use of nonsteroidal drugs, analgesics, and sedatives; 9. Other situations deemed unsuitable for inclusion by researchers.

Design outcomes

Primary

MeasureTime frame
The incidence of hypotension within 10 minutes after intubation (Hypotension is defined as systolic blood pressure20% within 10 minutes;

Secondary

MeasureTime frame
Blood pressure;heart rate;Oxygen saturation;Respiratory rate;Induction time;Intubation time;Awake time;Incidence of adverse events;

Countries

China

Contacts

Public ContactShirong Lin

The first affiliated hostipal of nanchang university

doctorlong3805@sina.com+86 791 8631 9353

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026